|
|
||||||||
1 Depts of Pulmonary diseases, and 2 Allergology, University Hospital Groningen, the Netherlands, and 3 Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA
CORRESPONDENCE:
To the Editor:
We read with great interest the paper by Maestrelli et al. 1 recently published in the European Respiratory Journal (ERJ). They showed a lower expression of haem oxygenase-1 (HO-1) in alveolar macrophages in lung tissue samples of patients with chronic obstructive pulmonary disease (COPD) than of controls. Unfortunately, the authors included a mixed group of smokers and nonsmokers. This makes their results more difficult to interpret since cigarette smoke is known to influence HO-1 expression as shown in an earlier paper by the same authors 2. Furthermore, the lung tissue samples in their COPD patient group were mainly derived by lung volume resection surgery and in the control group from resection because of lung cancer 1. We have recently analysed bronchoalveolar lavage (BAL) fluid of exsmokers with COPD and compared these to healthy exsmokers thereby ruling out the effects of current smoking history.
Thirteen patients with COPD, according to American Thoracic Society (ATS) criteria, were included with a mean age of 64 yrs, forced expiratory volume in one second (FEV1) 59% predicted, reversibility 6.0% of pred FEV1, and 26 pack-yrs of smoking. Eleven age matched control subjects were recruited, with a mean age of 58 yrs, FEV1 103% pred, reversibility 3.4% of pred FEV1, and 25 pack-yrs 3. All subjects had no history of asthma or atopy and had a negative skin test for 18 common aeroallergens. Treatment with inhaled corticosteroids was discontinued at least 1 month prior to the study and no treatment with oral corticosteroids and antibiotics was allowed in the same period. The airways were lavaged, using the first 50 mL for bronchial wash and the subsequent 150 mL for bronchoalveolar lavage as described previously 3. The lavage alveolar macrophage count was comparable in both groups. Immunostaining of cytospins was performed with a monoclonal antibody against HO-1 (Beckton Dickinson, Franklin Lakes, NJ, USA). Total HO-1 expression on macrophages was scored semi-quantitatively in a blinded panel by two independent observers; scores ranged from 0 (negative), 1, 2, to 3 (maximal) according to increasing intensity. Four hundred alveolar macrophages were counted on two slides and the HO-1 scores were added up. The overall HO-1 expression of BAL alveolar macrophages was significantly lower in the exsmoking COPD patients when compared to the healthy exsmoking controls (fig. 1
).
|
References
This article has been cited by other articles:
![]() |
E. Bathoorn, D-J. Slebos, D. S. Postma, G. H. Koeter, A. J. M. van Oosterhout, M. van der Toorn, H. M. Boezen, and H. A. M. Kerstjens Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Eur. Respir. J., December 1, 2007; 30(6): 1131 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Slebos, S. W. Ryter, M. van der Toorn, F. Liu, F. Guo, C. J. Baty, J. M. Karlsson, S. C. Watkins, H. P. Kim, X. Wang, et al. Mitochondrial Localization and Function of Heme Oxygenase-1 in Cigarette Smoke-Induced Cell Death Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 409 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Fredenburgh, M. A. Perrella, and S. A. Mitsialis The Role of Heme Oxygenase-1 in Pulmonary Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |